[Avian2005] Vaccine Aims to Wipe Out Ear, Sinus Infections

[Guest guest]

He needs 400 guinea pigs--has only 20--bet these and future " recruits " are

" foster kids "

 

Is it possible that this well funded technocrat puts a little too much weight

on " established by the EPA? "

 

Mercury in Vaccines: A Newsmaker Interview With Michael E. Pichichero, MD

Dr. Pichichero: *We looked at the [blood] level of mercury in children who

received thimerosal-containing vaccines. Not a single child had a blood mercury

level approaching the lower safety limit established by the EPA. "

http://www.medscape.com/viewarticle/445538

 

see also-- FEDERAL BIOTECH/MEDICAL RESEARCH GRANTS SETS RECORD " The

surge of new funding to our world-class universities, medical research centers

and biotech ... The Rockefeller University. 72.6. SUNY at Stony Brook ...

www.nystar.state.ny.us/pr/05/press27-05.htm - 16k

 

Keep the faith, beware the needle, UncBob

see also http://www.guineapigzero.com/index.html

 

 

 

Avian2005 , Carol Ann <saffireskyes wrote:

 

Vaccine Aims to Wipe Out Ear, Sinus Infections

 

POSTED: 1040 GMT (1840 HKT), September 26, 2006

 

WASHINGTON (Reuters) -- U.S. researchers said Tuesday that they are

starting trials of a new vaccine aimed at wiping out childhood ear and

sinus infections and many cases of bronchitis in adults.

 

Unlike virtually all other vaccines on the market, this one will not be

aimed at saving lives, but at preventing nuisance illnesses, the

researchers said.

 

" We are now in an era where we look to vaccines that make life better, "

said Dr. Michael Pichichero, a professor of microbiology, immunology,

pediatrics, and medicine at the University of Rochester Medical Center,

who is leading the trial.

 

The vaccine will target Nontypeable Haemophilus influenzae or NTHi,

which is the main remaining cause of ear and sinus infections and

bronchitis, now that vaccines exist for various forms of streptococcal

bacteria and Haemophilus influenzae B, the previous leading causes.

 

" For ear infections they are the No. 1 cause, for sinus infections they

are the No. 1 cause and for bronchitis in adults they are the No. 1

cause, but they do not invade the bloodstream and cause life-threatening

illness in normal people, " Pichichero said in a telephone interview.

 

While ear infections are never fatal, they can cause serious damage in

some children, Pichichero noted. He said 83 percent of U.S. children

experience one or more ear infections by age 3 and in some cases hearing

loss becomes permanent.

 

And the infections force children to visit clinics and emergency rooms,

and are the leading reason for antibiotic prescriptions. Experts agree

antibiotics are overused in the United States, which wastes money and

also helps " superbug " bacteria evolve that resist the drugs.

 

A team at Rochester also helped develop the vaccine marketed by Wyeth as

Prevnar, used to protect infants and toddlers against some bacteria

strains that can cause pneumonia, meningitis and ear infections.

 

GlaxoSmithKline is working on a rival to Prevnar.

 

The U.S. Centers for Disease Control and Prevention says Prevnar's use

has reduced pneumonia rates from the streptococcal strains it targets by

78 percent.

 

The University of Rochester announced on Tuesday it had won a $3.5

million grant from the National Institute of Deafness and Communication

Disorders, one of the National Institutes of Health, to develop the new

vaccine.

 

" I think the reason that this one has not moved forward at a faster pace

despite the discovery of the potential vaccine ingredients ... (is that)

up to now virtually all our vaccines have been focused on

life-threatening illness, " Pichichero said.

 

The vaccine uses little pieces of the bacteria that cause the infections

to stimulate an immune response. As the bacteria are all in the same

family, it should protect against a broad range of strains, Pichichero said.

 

Testing has begun. " We plan to enroll a total of 400 children and so far

have enrolled 20, " he said.

 

The university also has a $500,000 grant from the Thrasher Foundation,

which pays for research into pediatric diseases, to study a new vaccine

against Streptococcus pneumoniae strains not included in Prevnar's

formulation.

 

" Our ultimate goal would be to combine the three ingredients from the

Nontypeable Haemophilus influenzae vaccine with the streptococcal

vaccine, giving a vaccine that would prevent 90 percent of ear

infections, sinus infections and bronchitis, " Pichichero said.

 

That would leave cold viruses as the leading cause of respiratory

diseases, he said.

 

 

 

Carol Ann

 

People should not be afraid of their Governments. Governments should be afraid

of their people.

" V "

 

 

 

 

 

 

Messenger with Voice. Make PC-to-Phone Calls to the US (and 30+

countries) for 2¢/min or less.